Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v24-EN Version v2-FR
Language English French
Date Updated 2023-06-09 2022-06-30
Drug Identification Number 00637750 00637750
Brand name TEVA-LORAZEPAM TEVA-LORAZEPAM
Common or Proper name TEVA-LORAZEPAM 2MG TABLETS TEVA-LORAZEPAM 2MG TABLETS
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients LORAZEPAM LORAZEPAM
Strength(s) 2MG 2MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 1000 100,1000
ATC code N05BA N05BA
ATC description ANXIOLYTICS ANXIOLYTICS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-06-30 2022-06-30
Estimated end date 2023-05-10 2022-08-30
Actual end date 2023-06-08
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments